West Pharmaceutical Services, Inc. (WST)
NYSE - Nasdaq Real-time price. Currency in USD
Add to watchlist
At close: 04:00PM EDT
After hours:
Currency in USD
Valuation measures4
| Market cap (intra-day) | 27.62B |
| Enterprise value | 27.08B |
| Trailing P/E | 47.88 |
| Forward P/E | 49.51 |
| PEG ratio (5-yr expected) | 6.68 |
| Price/sales (ttm) | 9.63 |
| Price/book (mrq) | 9.59 |
| Enterprise value/revenue | 9.18 |
| Enterprise value/EBITDA | 32.07 |
Trading information
Stock price history
| Beta (5Y monthly) | 1.02 |
| 52-week change 3 | 3.13% |
| S&P500 52-week change 3 | 21.23% |
| 52-week high 3 | 415.73 |
| 52-week low 3 | 310.42 |
| 50-day moving average 3 | 380.64 |
| 200-day moving average 3 | 371.26 |
Share statistics
| Avg vol (3-month) 3 | 529.15k |
| Avg vol (10-day) 3 | 321.67k |
| Shares outstanding 5 | 73.21M |
| Implied shares outstanding 6 | 73.44M |
| Float 8 | 72.82M |
| % held by insiders 1 | 0.56% |
| % held by institutions 1 | 95.84% |
| Shares short (28 Mar 2024) 4 | 1.13M |
| Short ratio (28 Mar 2024) 4 | 2.3 |
| Short % of float (28 Mar 2024) 4 | 2.02% |
| Short % of shares outstanding (28 Mar 2024) 4 | 1.55% |
| Shares short (prior month 29 Feb 2024) 4 | 1.2M |
Dividends & splits
| Forward annual dividend rate 4 | 0.8 |
| Forward annual dividend yield 4 | 0.21% |
| Trailing annual dividend rate 3 | 0.77 |
| Trailing annual dividend yield 3 | 0.20% |
| 5-year average dividend yield 4 | 0.26 |
| Payout ratio 4 | 9.77% |
| Dividend date 3 | 01 May 2024 |
| Ex-dividend date 4 | 23 Apr 2024 |
| Last split factor 2 | 2:1 |
| Last split date 3 | 27 Sept 2013 |
Financial highlights
Fiscal year
| Fiscal year ends | 31 Dec 2023 |
| Most-recent quarter (mrq) | 31 Dec 2023 |
Profitability
| Profit margin | 20.12% |
| Operating margin (ttm) | 23.63% |
Management effectiveness
| Return on assets (ttm) | 11.93% |
| Return on equity (ttm) | 21.32% |
Income statement
| Revenue (ttm) | 2.95B |
| Revenue per share (ttm) | 39.70 |
| Quarterly revenue growth (yoy) | 3.30% |
| Gross profit (ttm) | N/A |
| EBITDA | 847.8M |
| Net income avi to common (ttm) | 593.4M |
| Diluted EPS (ttm) | 7.89 |
| Quarterly earnings growth (yoy) | 33.00% |
Balance sheet
| Total cash (mrq) | 853.9M |
| Total cash per share (mrq) | 11.65 |
| Total debt (mrq) | 309M |
| Total debt/equity (mrq) | 10.73% |
| Current ratio (mrq) | 2.88 |
| Book value per share (mrq) | 39.20 |
Cash flow statement
| Operating cash flow (ttm) | 776.5M |
| Levered free cash flow (ttm) | 199.04M |
© 2024 Yahoo. All rights reserved.